Cargando…
Impact of screening and exclusion of high anti‐A titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment: A hospital‐based cohort study in the US
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725686/ https://www.ncbi.nlm.nih.gov/pubmed/28983941 http://dx.doi.org/10.1002/ajh.24931 |
| _version_ | 1783285583059091456 |
|---|---|
| author | Martinez, Carlos Watson, Douglas J. Shebl, Amgad Wallenhorst, Christopher Hubsch, Alphonse Simon, Toby L. |
| author_facet | Martinez, Carlos Watson, Douglas J. Shebl, Amgad Wallenhorst, Christopher Hubsch, Alphonse Simon, Toby L. |
| author_sort | Martinez, Carlos |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5725686 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-57256862017-12-12 Impact of screening and exclusion of high anti‐A titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment: A hospital‐based cohort study in the US Martinez, Carlos Watson, Douglas J. Shebl, Amgad Wallenhorst, Christopher Hubsch, Alphonse Simon, Toby L. Am J Hematol Correspondence John Wiley and Sons Inc. 2017-10-31 2018-01 /pmc/articles/PMC5725686/ /pubmed/28983941 http://dx.doi.org/10.1002/ajh.24931 Text en © 2017 The Authors American Journal of Hematology Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial (http://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Correspondence Martinez, Carlos Watson, Douglas J. Shebl, Amgad Wallenhorst, Christopher Hubsch, Alphonse Simon, Toby L. Impact of screening and exclusion of high anti‐A titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment: A hospital‐based cohort study in the US |
| title | Impact of screening and exclusion of high anti‐A titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment: A hospital‐based cohort study in the US |
| title_full | Impact of screening and exclusion of high anti‐A titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment: A hospital‐based cohort study in the US |
| title_fullStr | Impact of screening and exclusion of high anti‐A titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment: A hospital‐based cohort study in the US |
| title_full_unstemmed | Impact of screening and exclusion of high anti‐A titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment: A hospital‐based cohort study in the US |
| title_short | Impact of screening and exclusion of high anti‐A titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment: A hospital‐based cohort study in the US |
| title_sort | impact of screening and exclusion of high anti‐a titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment: a hospital‐based cohort study in the us |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725686/ https://www.ncbi.nlm.nih.gov/pubmed/28983941 http://dx.doi.org/10.1002/ajh.24931 |
| work_keys_str_mv | AT martinezcarlos impactofscreeningandexclusionofhighantiatiterdonorsontheriskofhemolyticanemiawithintravenousimmunoglobulintreatmentahospitalbasedcohortstudyintheus AT watsondouglasj impactofscreeningandexclusionofhighantiatiterdonorsontheriskofhemolyticanemiawithintravenousimmunoglobulintreatmentahospitalbasedcohortstudyintheus AT sheblamgad impactofscreeningandexclusionofhighantiatiterdonorsontheriskofhemolyticanemiawithintravenousimmunoglobulintreatmentahospitalbasedcohortstudyintheus AT wallenhorstchristopher impactofscreeningandexclusionofhighantiatiterdonorsontheriskofhemolyticanemiawithintravenousimmunoglobulintreatmentahospitalbasedcohortstudyintheus AT hubschalphonse impactofscreeningandexclusionofhighantiatiterdonorsontheriskofhemolyticanemiawithintravenousimmunoglobulintreatmentahospitalbasedcohortstudyintheus AT simontobyl impactofscreeningandexclusionofhighantiatiterdonorsontheriskofhemolyticanemiawithintravenousimmunoglobulintreatmentahospitalbasedcohortstudyintheus |